Attogenix Biosystems

Attogenix Biosystems Pte Ltd is a Singapore biotechnology company. Founded in 2002, as a spin-off from Nanyang Technological University and the DSO National Laboratories, the company's product focus is on nucleic acid testing platforms with emphasis on infectious disease detection (such as dengue fever, SARS), genome profiling and applications for countering bioterrorism. In 2005, the company developed a biochip called AttoChip which has successfully undergone an independent clinical trial conducted by Tan Tock Seng Hospital and is 98 percent accurate. The AttoChip identifies genes, viruses and bacteria-causingdiseases from a blood sample. It can detect the presence of the dengue virus within two to three days of the onset of the virus.